Keeping Track: Submissions Galore, Blincyto Supplemental Approval, And Priority Review For Opdivo/Yervoy Combo
Executive Summary
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Keeping Track: A Week Of Calm As Shutdown Drags On
The latest drug development news and highlights from our US FDA Performance Tracker.
Vitrakvi, Daurismo Approvals Put US FDA On Brink Of Another Record
New oncologics bring CDER’s novel agent approvals count to 53 for the year.
New EMA Filings: Speedy Review For Lanadelumab But Cemiplimab Gets Standard Treatment
Shire and Regeneron/Sanofi are among the companies that have recently submitted investigational new treatments for approval across the EU.